Assessment of Personalized Risk in Patients with Melanoma 

A risk assessment tool has been developed to help better inform patients on their risk of recurrence from melanoma skin cancer. We have validated this tool in our region to ensure that it provides accurate information. This information can be used by physicians to help advise patients on the seriousness of their cancer diagnosis, and decide on further treatments, including immunotherapy. ​